Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension
NCT00160225 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2007-11-14
Summary
This study is to evaluate the end of treatment effect of Daglutril compared to placebo on top of losartan.
Conditions
Interventions
- DRUG
-
Daglutril
Sponsors & Collaborators
-
Solvay Pharmaceuticals
lead INDUSTRY
Principal Investigators
-
Global Clinical Director Solvay · Solvay Pharmaceuticals
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-07-31
Countries
- Italy
Study Locations
More Related Trials
-
Research Study To Test Carvedilol CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure
NCT00624065 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate Tonlamarsen for the Treatment of Adults With Uncontrolled Hypertension (KARDINAL)
NCT06864104 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Efficacy and Tolerability of Micardis®/Micardis® Plus in Patients With Hypertension
NCT02242357 ·Status: COMPLETED
-
Obese Hypertension Study (0954-315)
NCT00289887 ·Status: COMPLETED ·Phase: PHASE3
-
Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes
NCT00240422 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate ALN-AGT01 in Patients With Hypertension
NCT03934307 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin
NCT00185094 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Safety, Tolerability, and Efficacy of Monthly Subcutaneous Administration of ION904 in Participants With Uncontrolled Hypertension
NCT05314439 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Cohort Study to Evaluate the Safety and Efficacy of Micardis Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertensive Patients Under Real Life Conditions in Usual Clinical Practice
NCT00982735 ·Status: COMPLETED
-
Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes
NCT00160160 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Efficacy and Safety of HGP2102 in Essential Hypertension Patients
NCT06174766 ·Status: RECRUITING ·Phase: PHASE3
-
Study to Evaluate the Effect of the Treatment With Micardis® or MicardisPlus® on Blood Pressure
NCT02242864 ·Status: COMPLETED
-
Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without Diabetes
NCT03978884 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Study to Investigate the Efficacy and Safety of Different Doses of Losartan Potassium (MK0954-011)
NCT00882440 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Telmisartan Compared With Losartan
NCT06431477 ·Status: RECRUITING ·Phase: PHASE4
-
I PREVENT - Irbesartan In Hypertensive Diabetic Patients
NCT00362258 ·Status: COMPLETED ·Phase: PHASE4
-
A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With Hypertension
NCT00635232 ·Status: COMPLETED ·Phase: PHASE2
-
Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension
NCT06608472 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension
NCT04936035 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Losartan and Losartan Plus Isosorbide Mononitrate on Central Blood Pressure Measurements (0954-317)
NCT00943852 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Evaluate the Safety and Efficacy of PS433540 to Treat Hypertension
NCT00522925 ·Status: COMPLETED ·Phase: PHASE2
-
Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema
NCT01919801 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605
NCT02916602 ·Status: COMPLETED ·Phase: PHASE3
-
I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy
NCT00362037 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment
NCT01620788 ·Status: SUSPENDED ·Phase: PHASE3